Lasa Supergenerics (LASA.NS) Stock Price
Lasa Supergenerics Price
Revenue at Lasa Supergenerics has contracted by 20.5% per year over the past 9 years to 251.41 M INR. Earnings per share have grown at 52.7% per year over the last 4 years. For Lasa Supergenerics, the net margin of -135.6% is down versus -3.9% a few years ago. At today's price the dividend yield works out to roughly 5.92%. The payout ratio is around 4% of earnings.
Lasa Supergenerics stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Lasa Supergenerics business model & stock analysis
Frequently asked questions about Lasa Supergenerics
Converted at the current exchange rate, the Lasa Supergenerics share trades at 0.04 EUR (4.22 INR).
The revenue of Lasa Supergenerics is 251.41 M INR. This figure is based on current financial data and reflects the company's business performance.
The profit of Lasa Supergenerics is -340.90 M INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Lasa Supergenerics is currently -0.62. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Lasa Supergenerics stock.
The price-to-sales ratio (P/S) of Lasa Supergenerics is currently 0.84. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Lasa Supergenerics stock.
The Eulerpool Quality Score for Lasa Supergenerics is 1/10.
The ISIN of Lasa Supergenerics is INE670X01014. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Lasa Supergenerics is LASA.NS. The ticker symbol is used to trade Lasa Supergenerics shares on the stock exchange.
Lasa Supergenerics stock
Lasa Supergenerics Peer Group
Lasa Supergenerics FIGI
All fundamentals and in-depth analysis of Lasa Supergenerics
Our stock analysis for Lasa Supergenerics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lasa Supergenerics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.